MIMEDX GROUP, INC.MDXGEarnings & Financial Report
MiMedx is an American biomedical company based in Marietta, Georgia, founded in 2008. Using tissues from birth such as the placenta, amniotic sac, and umbilical cord, MiMedx creates skin for skin grafts for medical use.
MDXG Q4 2025 Key Financial Metrics
売上高
$118.1M
粗利益
$99.0M
営業利益
$21.1M
純利益
$15.2M
粗利益率
83.9%
営業利益率
17.8%
純利益率
12.9%
前年比成長
27.1%
EPS
$0.10
資金フロー
MIMEDX GROUP, INC. Q4 2025 Financial Summary
MIMEDX GROUP, INC. reported revenue of $118.1M (up 27.1% YoY) for Q4 2025, with a net profit of $15.2M (up 104.2% YoY) (12.9% margin). Cost of goods sold was $19.1M, operating expenses totaled $78.0M.
Key Financial Metrics
| Total Revenue | $118.1M |
|---|---|
| Net Profit | $15.2M |
| Gross Margin | 83.9% |
| Operating Margin | 17.8% |
| Report Period | Q4 2025 |
Revenue Breakdown
MIMEDX GROUP, INC. Q4 2025 revenue of $118.1M breaks down across 2 segments, led by Wound at $78.7M (66.6% of total).
| Segment | Revenue | % of Total |
|---|---|---|
| Wound | $78.7M | 66.6% |
| Surgical | $39.4M | 33.4% |
MIMEDX GROUP, INC. Revenue by Segment — Quarterly Trend
MIMEDX GROUP, INC. revenue by segment across the last 4 reported quarters, showing how each business line (such as Wound and Surgical) has evolved quarter over quarter.
| Segment | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|
| Wound | $78.7M | $77.1M | $64.5M | $56.1M |
| Surgical | $39.4M | $36.6M | $34.1M | $32.1M |
MIMEDX GROUP, INC. Annual Revenue by Year
MIMEDX GROUP, INC. annual revenue history includes year-by-year totals (for example, 2025 revenue was $418.6M). Click any linked year to see what changed vs the prior 10-K.
MIMEDX GROUP, INC. Quarterly Revenue & Net Profit History
MIMEDX GROUP, INC. quarterly results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q4 2025 | $118.1M | +27.1% | $15.2M | 12.9% |
| Q3 2025 | $113.7M | +35.3% | $16.7M | 14.7% |
| Q2 2025 | $98.6M | +13.1% | $9.6M | 9.8% |
| Q1 2025 | $88.2M | +4.1% | $7.0M | 8.0% |
| Q4 2024 | $92.9M | +7.0% | $7.4M | 8.0% |
| Q3 2024 | $84.1M | +2.9% | $8.1M | 9.6% |
| Q2 2024 | $87.2M | +7.3% | $17.6M | 20.2% |
| Q1 2024 | $84.7M | +18.2% | $9.3M | 10.9% |
損益計算書
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| 売上高 | $84.7M | $87.2M | $84.1M | $92.9M | $88.2M | $98.6M | $113.7M | $118.1M |
| 前年比成長 | 18.2% | 7.3% | 2.9% | 7.0% | 4.1% | 13.1% | 35.3% | 27.1% |
貸借対照表
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| 総資産 | $221.7M | $230.2M | $243.9M | $263.9M | $270.4M | $291.1M | $319.0M | $342.7M |
| 総負債 | $66.0M | $62.1M | $62.9M | $70.8M | $67.6M | $74.5M | $80.0M | $86.1M |
| 株主資本 | $155.7M | $168.0M | $181.0M | $193.1M | $202.8M | $216.6M | $238.9M | $256.5M |
キャッシュフロー
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| 営業CF | $6.0M | $21.8M | $19.6M | $18.8M | $5.3M | $14.4M | $29.3M | $25.0M |